Contineum Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Contineum Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Contineum Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Contineum Therapeutics by Barclays
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $158k | 8.3k | 19.02 |
2024-06-30 | $42k | 2.4k | 17.62 |